Uca Finvest Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 2.04 Cr
- Company Age 36 Year, 16 Days
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 2768.65%
- Profit Growth 2933.98%
- Ebitda 2604.54%
- Net Worth 26.12%
- Total Assets 289.90%
About Uca Finvest
Uca Finvest Private Limited (UFPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 16 January 1989 and has a history of 36 years. Its registered office is in Delhi, India.
The Corporate was formerly known as Medirose Drugs Private Limited. The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.04 Cr, as per Ministry of Corporate Affairs (MCA) records.
Karan Singal, Rajni Gupta, Rahul Jha, and Two other members serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74899DL1989PTC034680
-
Company No.
034680
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 Jan 1989
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Uca Finvest?
Board Members (5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Karan Singal | Additional Director | 12-Apr-2024 | Current |
Rajni Gupta | Whole-Time Director | 20-Jan-2012 | Current |
Rahul Jha | Director | 25-Jan-2022 | Current |
Mahendra Sharma | Director | 22-Mar-2022 | Current |
Jitesh Kumar | Director | 01-Apr-2014 | Current |
Financial Performance of Uca Finvest.
Uca Finvest Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 2768.65% increase. The company also saw a substantial improvement in profitability, with a 2933.98% increase in profit. The company's net worth Soared by an impressive increase of 26.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Uca Finvest?
In 2023, Uca Finvest had a promoter holding of 18.69% and a public holding of 81.31%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Uca Finvest?
Unlock and access historical data on people associated with Uca Finvest, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Uca Finvest, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uca Finvest's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.